(Q64041044)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

title

C3 glomerulopathy - understanding a rare complement-driven renal disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Mihály Józsi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

John D. Lambris

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Marina Noris

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Giuseppe Remuzzi

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Sanjeev Sethi

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Johan Van Der Vlag

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Peter F Zipfel

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

David Kavanagh

9

0 references

Carla M Nester

object named as

Carla M Nester

Santiago Rodriguez de Córdoba

18

0 references

object named as

Santiago Rodriguez de Córdoba

14

0 references

author name string

Richard J H Smith

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Gerald B Appel

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

H Terence Cook

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Vivette D D'Agati

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Fadi Fakhouri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Véronique Fremeaux-Bacchi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

Matthew C Pickering

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

language of work or name

English

0 references

publication date

1 March 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

Nature Reviews Nephrology

20 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

page(s)

129-143

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

C3 glomerulopathy: consensus report

20 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

New approaches to the treatment of dense deposit disease

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

C3 glomerulonephritis and dense deposit disease share a similar disease course in a large United States cohort of patients with C3 glomerulopathy.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

C3 glomerulopathy: clinicopathologic features and predictors of outcome

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Acquired and genetic complement abnormalities play a critical role in dense deposit disease and other C3 glomerulopathies

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Familial C3 glomerulopathy associated with CFHR5 mutations: clinical characteristics of 91 patients in 16 pedigrees

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Effectiveness of mycophenolate mofetil in C3 glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Complement gene variants determine the risk of immunoglobulin-associated MPGN and C3 glomerulopathy and predict long-term renal outcome

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Allograft failure in kidney transplant recipients with membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Clinical findings, pathology, and outcomes of C3GN after kidney transplantation

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

C3 glomerulopathy: what's in a name?

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Glomeruli of Dense Deposit Disease contain components of the alternative and terminal complement pathway

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Complement activation in pauci-immune necrotizing and crescentic glomerulonephritis: results of a proteomic analysis.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Membranoproliferative glomerulonephritis--a new look at an old entity

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Toward a working definition of C3 glomerulopathy by immunofluorescence

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Diagnostic accuracy of immunofluorescence versus immunoperoxidase staining to distinguish immune complex-mediated glomerulonephritis and C3 dominant glomerulopathy.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Atypical postinfectious glomerulonephritis is associated with abnormalities in the alternative pathway of complement

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Revisiting post-infectious glomerulonephritis in the emerging era of C3 glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

A proposal for standardized grading of chronic changes in native kidney biopsy specimens.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Complement component C3 - The "Swiss Army Knife" of innate immunity and host defense

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Properdin: a tightly regulated critical inflammatory modulator

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Structure of complement fragment C3b-factor H and implications for host protection by complement regulators

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Modulation of the alternative complement pathways by beta 1 H globulin

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

The complement factor H-related proteins

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Familial C3 glomerulonephritis caused by a novel CFHR5-CFHR2 fusion gene

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Dimerization of complement factor H-related proteins modulates complement activation in vivo

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

C3 glomerulopathy-associated CFHR1 mutation alters FHR oligomerization and complement regulation

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Hereditary porcine membranoproliferative glomerulonephritis type II is caused by factor H deficiency

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Loss of properdin exacerbates C3 glomerulopathy resulting from factor H deficiency

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Combination of factor H mutation and properdin deficiency causes severe C3 glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Prevention of C5 activation ameliorates spontaneous and experimental glomerulonephritis in factor H-deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Resolution of the three dimensional structure of components of the glomerular filtration barrier

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Global analysis reveals the complexity of the human glomerular extracellular matrix

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Visualization of the glomerular endothelial glycocalyx by electron microscopy using cationic colloidal thorium dioxide

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Mutations in Complement Factor H Impair Alternative Pathway Regulation on Mouse Glomerular Endothelial Cells in Vitro

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Structure of the Extracellular Portion of CD46 Provides Insights into Its Interactions with Complement Proteins and Pathogens

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Complement Factor H-Related 5-Hybrid Proteins Anchor Properdin and Activate Complement at Self-Surfaces

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Complement factor H-related hybrid protein deregulates complement in dense deposit disease

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Identification of a mutation in complement factor H-related protein 5 in patients of Cypriot origin with glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

A hybrid CFHR3-1 gene causes familial C3 glomerulopathy.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

A novel CFHR1-CFHR5 hybrid leads to a familial dominant C3 glomerulopathy.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

C3d fragment of complement interacts with laminin and binds to basement membranes of glomerulus and trophoblast

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

High-Throughput Genetic Testing for Thrombotic Microangiopathies and C3 Glomerulopathies

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Statistical Validation of Rare Complement Variants Provides Insights into the Molecular Basis of Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Complement receptor 3 mediates renal protection in experimental C3 glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Causes of alternative pathway dysregulation in dense deposit disease

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

C5 nephritic factors drive the biological phenotype of C3 glomerulopathies

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Anti-factor H autoantibodies in C3 glomerulopathies and in atypical hemolytic uremic syndrome: one target, two diseases

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Anti-Factor B and Anti-C3b Autoantibodies in C3 Glomerulopathy and Ig-Associated Membranoproliferative GN.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

C4 Nephritic Factors in C3 Glomerulopathy: A Case Series.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Anti-factor B autoantibody in dense deposit disease

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Testing the Activity of Complement Convertases in Serum/Plasma for Diagnosis of C4NeF-Mediated C3 Glomerulonephritis.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Activation of the alternative pathway of complement by monoclonal lambda light chains in membranoproliferative glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

C3 glomerulopathy associated with monoclonal Ig is a distinct subtype

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

C3 Glomerulopathy: Ten Years' Experience at Mayo Clinic

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Dense deposit disease: clinicopathologic study of 32 pediatric and adult patients

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

1 reference

7 January 2021

Primary glomerulonephritis with isolated C3 deposits: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Treatment of B-cell disorder improves renal outcome of patients with monoclonal gammopathy-associated C3 glomerulopathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

C3 glomerulopathy in adults: a distinct patient subset showing frequent association with monoclonal gammopathy and poor renal outcome

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a "Kidney Disease: Improving Global Outcomes" (KDIGO) Controversies Conference.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

HMG-CoA reductase inhibitors for the prevention of nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Hyperlipidemia and thrombotic complications in patients with membranous nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Successful plasma therapy for atypical hemolytic uremic syndrome caused by factor H deficiency owing to a novel mutation in the complement cofactor protein domain 15.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Management of membranoproliferative glomerulonephritis type II with plasmapheresis.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Mycophenolate Mofetil in Combination with Steroids for Treatment of C3 Glomerulopathy: A Case Series.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Complement inhibition in C3 glomerulopathy.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Eculizumab for dense deposit disease and C3 glomerulonephritis

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Patterns of Clinical Response to Eculizumab in Patients With C3 Glomerulopathy.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Clinical features and outcomes of 98 children and adults with dense deposit disease.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.

1 reference

https://api.crossref.org/works/10.1038%2FS41581-018-0107-2

7 January 2021

Glomerular immune deposits in kidneys from patients with no clinical or light microscopic evidence of glomerulonephritis. Assessment of the influence of autolysis on identification of immunoglobulins and complement

1 reference

12 December 2020

Immunopathology of the end-stage kidney. Immunoglobulin and complement component deposition in nonimmune disease

1 reference

12 December 2020

Factor I is required for the development of membranoproliferative glomerulonephritis in factor H-deficient mice

1 reference

12 December 2020

Human factor H-related protein 2 (CFHR2) regulates complement activation

1 reference

12 December 2020

Characterization of C3 in C3 glomerulopathy

1 reference

12 December 2020

10.1038/S41581-018-0107-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:30692664%20AND%20SRC:MED&resulttype=core&format=json

20 April 2020

1 reference